Research Article
The Effects of Bromocriptine on Preventing Postpartum Flare in Systemic Lupus Erythematosus Patients from South China
Table 1
Baseline demographic features, clinical findings, and SLEDAI scores in the pregnant SLE patients.
| | Treatment group () | Control group () | value |
| Age (years, mean ± SD) | 30.47 ± 4.33 | 30.02 ± 3.95 | 0.57 | Disease duration (years, mean ± SD) | 3.27 ± 0.91 | 3.45 ± 1.12 | 0.63 | Inactive SLE (%) | 8 (21.05%) | 8 (21.05%) | 1.00 | C3 (g/L, mean ± SD) | 0.56 ± 0.29 | 0.58 ± 0.21 | 0.51 | C4 (g/L, mean ± SD) | 0.13 ± 0.06 | 0.14 ± 0.05 | 0.54 | SLEDAI score (mean ± SD) | 7.13 ± 1.37 | 6.92 ± 1.98 | 0.43 |
|
|
SLEDAI: systemic lupus erythematosus disease activity index.
|